225 related articles for article (PubMed ID: 30962272)
1. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma.
Wang Y; Wu J; Xu J; Lin S
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962272
[TBL] [Abstract][Full Text] [Related]
2. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro.
Wang H; Wu K; Sun Y; Li Y; Wu M; Qiao Q; Wei Y; Han ZG; Cai B
BMB Rep; 2012 Nov; 45(11):629-34. PubMed ID: 23187001
[TBL] [Abstract][Full Text] [Related]
3. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
5. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
6. Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance.
Ma HX; Shu QH; Pan JJ; Liu D; Xu GL; Li JS; Ma JL; Jia WD; Yv JH; Ge YS
Tumour Biol; 2015 Jun; 36(6):4235-41. PubMed ID: 25592379
[TBL] [Abstract][Full Text] [Related]
7. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
8. STC2 as a novel mediator for Mus81-dependent proliferation and survival in hepatocellular carcinoma.
Wu F; Li TY; Su SC; Yu JS; Zhang HL; Tan GQ; Liu JW; Wang BL
Cancer Lett; 2017 Mar; 388():177-186. PubMed ID: 27939696
[TBL] [Abstract][Full Text] [Related]
9. Expression of stanniocalcin-1 and stanniocalcin-2 in laryngeal squamous cell carcinoma and correlations with clinical and pathological parameters.
Zhou H; Li YY; Zhang WQ; Lin D; Zhang WM; Dong WD
PLoS One; 2014; 9(4):e95466. PubMed ID: 24743310
[TBL] [Abstract][Full Text] [Related]
10. Expression of Stanniocalcin 2 in Breast Cancer and Its Clinical Significance.
Jiang ST; Wang HQ; Yang TC; Wang DW; Yang LJ; Xi YQ; Kong FZ; Pan XK; Xu LH; Feng MH; Xie W; Su F
Curr Med Sci; 2019 Dec; 39(6):978-983. PubMed ID: 31845230
[TBL] [Abstract][Full Text] [Related]
11. Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma.
Zhang ZH; Wu YG; Qin CK; Rong ZH; Su ZX; Xian GZ
Oncol Lett; 2014 Nov; 8(5):2160-2164. PubMed ID: 25289096
[TBL] [Abstract][Full Text] [Related]
12. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
13. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
Hu X; He B; Zhou L; Xie H; Zheng S
Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Stanniocalcin2 mRNA Expression in Patients With Colorectal Cancer.
Watanabe T; Shiozawa M; Kimura Y; Hiroshima Y; Hashimoto I; Komori K; Watanabe H; Kano K; Fujikawa H; Aoyama T; Numata M; Yamada T; Tamagawa H; Ogata T; Yukawa N; Morinaga S; Rino Y; Masuda M; Miyagi Y; Oshima T
Anticancer Res; 2021 Apr; 41(4):2117-2122. PubMed ID: 33813422
[TBL] [Abstract][Full Text] [Related]
16. The correlation of NLRC3 expression with the progression and prognosis of hepatocellular carcinoma.
Ma YY; Zhang GH; Li J; Wang SB; Hu ZM; Zhang CW; Li E
Hum Pathol; 2018 Dec; 82():273-281. PubMed ID: 30081150
[TBL] [Abstract][Full Text] [Related]
17. High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis.
Shakya M; Zhou A; Dai D; Zhong Q; Zhou Z; Zhang Y; Li X; Bholee AK; Chen M
Cancer Biomark; 2018; 22(4):611-619. PubMed ID: 29843208
[TBL] [Abstract][Full Text] [Related]
18. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
19. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer.
Ieta K; Tanaka F; Yokobori T; Kita Y; Haraguchi N; Mimori K; Kato H; Asao T; Inoue H; Kuwano H; Mori M
Int J Cancer; 2009 Aug; 125(4):926-31. PubMed ID: 19415750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
